Genetic Rx to Feature Industry Leaders and Prominent Academics and Investors on Dec. 8th

Share Article

Prominent academics, leaders of the biopharmaceutical industry and key investors will gather on December 8th at Genetic Rx, a networking conference of the Boston Biotech Conferences series. Genetic Rx will take place at the Joseph B. Martin Conference Center at Harvard Medical School and focuses on the emergence of new genetic medicines and therapies, as well as the treatment of patients with rare and ultra-rare genetic diseases.

News Image
The Genetic Rx conference is an amazing venue to learn about advances in the field of genetic therapies and to meet the thought leaders in the community that are bringing the next generation of genetic therapies.

Prominent academics, leaders of the biopharmaceutical industry and key investors will gather on December 8th at Genetic Rx, a networking conference of the Boston Biotech Conferences series. Genetic Rx will take place at the Joseph B. Martin Conference Center at Harvard Medical School and focuses on the emergence of new genetic medicines and therapies, as well as the treatment of patients with rare and ultra-rare genetic diseases.

Speakers include Paul Bolno (WAVE Life Sciences), Jim Burns (Casebia Therapeutics), Belen Carrillo-Rivas (Pfizer), Oliver Fetzer (Synthetic Genomics), Terence Flotte (UMass Medical School), Kathy High (SPARK Therapeutics), Sven Kili (GlaxoSmithKline), Michael Linden (Pfizer), Harald Petry (uniQure), Jude Samulski (Bamboo Therapeutics), Sue Washer (AGTC) and many more. Leading investors from Bain Capital, Canaan Partners, New Leaf Ventures, Piper Jaffray, Sofinnova Ventures, and Third Rock Ventures will also be in attendance. 

Edward Kaye, CEO of Sarepta Therapeutics, says of the event, "The Genetic Rx conference is an amazing venue to learn about advances in the field of genetic therapies and to meet the thought leaders in the community that are bringing the next generation of genetic therapies."

“For those anxiously engaged in the dynamic field of genetic medicine, this conference is one of the ‘must-attend’ meetings of the year”, adds Joseph Payne, President & CEO of Arcturus Therapeutics.

Genetic Rx is sponsored by Pfizer and the BioPharma Executive Council.

For more information, please visit: http://bbbiotechconference.com/conference-agenda.php?id=45

ABOUT THE BOSTON BIOTECH CONFERENCES (BBC)

The Boston Biotech Conferences (BBC)’s mission is to build a vibrant community of bio-pharma leaders, which will help to drive innovation in biotech, and bring important drugs to patients more quickly. The conferences are exclusive, thought-leader forums for senior bio-pharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the bio-pharma community. The meetings are invitation-only, off-the-record forums that bring together the past, present and future leaders in the healthcare community to network, exchange ideas and share insights into the industry's challenges and opportunities. For more information or to register, visit http://www.bbbiotechconference.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cristina Ojeda
@BiotechConf
Follow >
Boston Biotech Conferences
since: 05/2012
Like >
Visit website